27234031|t|Improved diagnostic yield of neuromuscular disorders applying clinical exome sequencing in patients arising from a consanguineous population
27234031|a|Neuromuscular diseases (NMDs) include a broad range of disorders affecting muscles, nerves and neuromuscular junctions. Their overlapping phenotypes and heterogeneous genetic nature have created challenges in diagnosis which calls for the implementation of massive parallel sequencing as a candidate strategy to increase the diagnostic yield. In this study, total of 45 patients, mostly offspring of consanguineous marriages were examined using whole exome sequencing. Data analysis was performed to identify the most probable pathogenic rare variants in known NMD genes which led to identification of causal variants for 33 out of 45 patients (73.3%) in the following known genes: CAPN3, Col6A1, Col6A3, DMD, DYSF, FHL1, GJB1, ISPD, LAMA2, LMNA, PLEC1, RYR1, SGCA, SGCB, SYNE1, TNNT1 and 22 novel pathogenic variants were detected. Today, the advantage of whole exome sequencing in clinical diagnostic strategies of heterogeneous disorders is clear. In this cohort, a diagnostic yield of 73.3% was achieved which is quite high compared to the overall reported diagnostic yield of 25% to 50%. This could be explained by the consanguineous background of these patients and is another strong advantage of offering clinical exome sequencing in diagnostic laboratories, especially in populations with high rate of consanguinity.
27234031	0	8	Improved	T033	UMLS:C0184511
27234031	29	52	neuromuscular disorders	T038	UMLS:C0027868
27234031	71	87	exome sequencing	T062	UMLS:C3640077
27234031	130	140	population	T098	UMLS:C1257890
27234031	141	163	Neuromuscular diseases	T038	UMLS:C0027868
27234031	165	169	NMDs	T038	UMLS:C0027868
27234031	196	205	disorders	T038	UMLS:C0012634
27234031	216	223	muscles	T017	UMLS:C0026845
27234031	225	231	nerves	T017	UMLS:C0027740
27234031	236	259	neuromuscular junctions	T017	UMLS:C0027869
27234031	350	359	diagnosis	T033	UMLS:C0011900
27234031	398	425	massive parallel sequencing	T062	UMLS:C2936622
27234031	492	497	study	T062	UMLS:C2603343
27234031	586	608	whole exome sequencing	T062	UMLS:C3640077
27234031	668	678	pathogenic	T033	UMLS:C3816499
27234031	679	692	rare variants	T017	UMLS:C0678941
27234031	702	705	NMD	T038	UMLS:C0027868
27234031	706	711	genes	T017	UMLS:C0017337
27234031	816	821	genes	T017	UMLS:C0017337
27234031	823	828	CAPN3	T017	UMLS:C1413113
27234031	830	836	Col6A1	T017	UMLS:C1413589
27234031	838	844	Col6A3	T017	UMLS:C1413591
27234031	846	849	DMD	T017	UMLS:C1414083
27234031	851	855	DYSF	T017	UMLS:C1414209
27234031	857	861	FHL1	T017	UMLS:C1414612
27234031	863	867	GJB1	T017	UMLS:C1415076
27234031	869	873	ISPD	T017	UMLS:C2829592
27234031	875	880	LAMA2	T017	UMLS:C1416776
27234031	882	886	LMNA	T017	UMLS:C1416877
27234031	888	893	PLEC1	T017	UMLS:C1418643
27234031	895	899	RYR1	T017	UMLS:C1419778
27234031	901	905	SGCA	T017	UMLS:C1420005
27234031	907	911	SGCB	T017	UMLS:C1420006
27234031	913	918	SYNE1	T017	UMLS:C1424736
27234031	920	925	TNNT1	T017	UMLS:C1420827
27234031	939	949	pathogenic	T033	UMLS:C3816499
27234031	950	958	variants	T017	UMLS:C0678941
27234031	964	972	detected	T033	UMLS:C0442726
27234031	998	1020	whole exome sequencing	T062	UMLS:C3640077
27234031	1024	1043	clinical diagnostic	T058	UMLS:C0332140
27234031	1058	1081	heterogeneous disorders	T033	UMLS:C1858576
27234031	1100	1106	cohort	T098	UMLS:C0599755
27234031	1362	1378	exome sequencing	T062	UMLS:C3640077
27234031	1393	1405	laboratories	T092	UMLS:C0022877
27234031	1421	1432	populations	T098	UMLS:C1257890
27234031	1451	1464	consanguinity	T033	UMLS:C0009789